Valuation: SMAIO

Market Cap 44.27M 50.97M 41.11M 37.91M 71.42M 4.87B 72.71M 487M 191M 2.42B 191M 187M 8.13B P/E 2026 *
-20.2x
P/E 2027 * 197x
Enterprise Value 42.77M 49.24M 39.72M 36.63M 69M 4.7B 70.25M 470M 184M 2.33B 185M 181M 7.85B EV / Sales 2026 *
3.89x
EV / Sales 2027 * 2.71x
Free-Float
29.17%
Yield 2026 *
-
Yield 2027 * -
1 day+0.77%
1 week-4.15%
Current month+1.29%
1 month+1.29%
3 months+6.22%
6 months+12.29%
Current year+25.76%
1 week 7.3
Extreme 7.3
8.3
1 month 7.3
Extreme 7.3
8.94
Current year 6
Extreme 6
9.1
1 year 5.5
Extreme 5.5
9.1
3 years 2.14
Extreme 2.14
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.77%-4.15%+3.42%+211.90% 50M
-4.55%-2.61%+51.95%+151.91% 1,079B
-3.66%-1.33%+52.95%+46.62% 640B
-2.24%+0.19%+35.97%+70.64% 465B
-2.29%+1.12%+36.13%+31.18% 353B
-2.28%-0.69%+33.42%+40.48% 301B
-3.15%+0.25%+10.63%+15.03% 271B
-2.12%+3.31%+1.82%-37.38% 228B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 165B
Average -1.57%+4.35%+26.93%+66.52% 370.97B
Weighted average by Cap. -1.62%+4.86%+38.04%+72.89%

Financials

2026 *2027 *
Net sales 11M 12.66M 10.21M 9.42M 17.75M 1.21B 18.07M 121M 47.35M 600M 47.56M 46.52M 2.02B 16M 18.42M 14.86M 13.7M 25.81M 1.76B 26.28M 176M 68.87M 873M 69.17M 67.66M 2.94B
Net income -2.25M -2.59M -2.09M -1.93M -3.63M -247M -3.7M -24.74M -9.69M -123M -9.73M -9.51M -413M 250K 288K 232K 214K 403K 27.48M 411K 2.75M 1.08M 13.65M 1.08M 1.06M 45.89M
Net Debt -1.5M -1.73M -1.39M -1.28M -2.42M -165M -2.46M -16.49M -6.46M -81.88M -6.49M -6.34M -275M -900K -1.04M -836K -771K -1.45M -98.92M -1.48M -9.89M -3.87M -49.13M -3.89M -3.81M -165M
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
30/07/26 EUR 7.860 +0.77% 514
29/07/26 EUR 7.800 -2.50% 2,563
28/07/26 EUR 8.000 -1.23% 295
27/07/26 EUR 8.100 -2.41% 147
24/07/26 EUR 8.300 +1.22% 312
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.860EUR
Average target price
8.200EUR
Spread / Average Target
+4.33%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock